Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Bioessays ; 42(12): e2000198, 2020 12.
Article in English | MEDLINE | ID: covidwho-917076

ABSTRACT

The outbreak of a new, potentially fatal virus, SARS-COV-2, which started in December 2019 in Wuhan, China, and since developed into a pandemic has stimulated research for an effective treatment and vaccine. For this research to be successful, it is necessary to understand the pathology of the virus. So far, we know that this virus can harm different organs of the body. Although the exact mechanisms are still unknown, this phenomenon may result from the body's secretion of prostaglandin E2 (PGE2), which is involved in several inflammation and immunity pathways. Noticeably, the expression of this molecule can lead to a cytokine storm causing a variety of side effects. In this paper, we discuss those side effects in SARS-COV-2 infection separately to determine whether PGE2 is, indeed, an important causative factor. Lastly, we propose a mechanism by which PGE2 production increases in response to COVID-19 disease and suggest the possible direct relation between PGE2 levels and the severity of this disease. Also see the video abstract here: https://youtu.be/SnPFAcjxxKw.


Subject(s)
COVID-19/epidemiology , COVID-19/pathology , Dinoprostone/physiology , Pandemics , SARS-CoV-2/pathogenicity , Aging/physiology , Angiotensin-Converting Enzyme 2/metabolism , COVID-19/immunology , Dinoprostone/metabolism , Female , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Inflammation/complications , Inflammation/epidemiology , Inflammation/pathology , Inflammation/virology , Male , Phenotype , SARS-CoV-2/immunology , Severity of Illness Index , Signal Transduction/immunology
SELECTION OF CITATIONS
SEARCH DETAIL